H.Res. 1265

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 1265 Introduced in House (IH)]

<DOC>

119th CONGRESS
2d Session
H. RES. 1265

Expressing support for the designation of the week of May 3, 2026, 
through May 9, 2026, as ``Tardive Dyskinesia Awareness Week''.

_______________________________________________________________________

IN THE HOUSE OF REPRESENTATIVES

May 7, 2026

Mr. Peters (for himself, Mr. Bilirakis, Mr. Mullin, and Mr. Bean of 
Florida) submitted the following resolution; which was referred to the 
Committee on Energy and Commerce

_______________________________________________________________________

RESOLUTION

Expressing support for the designation of the week of May 3, 2026, 
through May 9, 2026, as ``Tardive Dyskinesia Awareness Week''.

Whereas many people living with serious mental illnesses (for example, bipolar 
disorder, major depressive disorder, schizophrenia, and schizoaffective 
disorder) or gastrointestinal disorders (for example, gastroparesis, 
upset stomach, nausea, and vomiting) may be treated with medications 
that work as dopamine receptor blocking agents, including antipsychotics 
and antiemetics;
Whereas, while ongoing treatment with these medications can be necessary, 
prolonged use may be associated with tardive dyskinesia (TD), an 
involuntary movement disorder that is characterized by uncontrollable, 
abnormal, and repetitive movements of the face, torso, limbs, and 
fingers or toes;
Whereas even mild symptoms of TD can impact people physically, socially, and 
emotionally;
Whereas it is estimated that TD affects approximately 600,000 people in the 
United States, and approximately 60 percent of people with TD have not 
been diagnosed, making it important to raise awareness about the 
symptoms;
Whereas it is important that people taking these medications be monitored for TD 
by a health care provider, and regular screening for TD is recommended 
by the American Psychiatric Association;
Whereas clinical research has led to approval of treatments for adults with TD 
by the Food and Drug Administration, and recognition and treatment of TD 
can make a positive impact in the lives of many people experiencing 
psychotic and mood disorders; and
Whereas the House of Representatives can raise awareness of TD among the public 
and medical community: Now, therefore, be it
Resolved, That the House of Representatives--
(1) expresses support for the designation of ``Tardive 
Dyskinesia Awareness Week''; and
(2) encourages each individual in the United States to 
become better informed about and aware of tardive dyskinesia.
<all>